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Renal hypodysplasia (RHD) is a heterogeneous condition encompassing a spectrum of kidney development defects including renal agen-
esis, hypoplasia, and (cystic) dysplasia. Heterozygous mutations of several genes have been identified as genetic causes of RHD with
various severity. However, these genes and mutations are not associated with bilateral renal agenesis, except for RETmutations, which
could be involved in a few cases. The pathophysiological mechanisms leading to total absence of kidney development thus remain
largely elusive. By using a whole-exome sequencing approach in families with several fetuses with bilateral renal agenesis, we identified
recessive mutations in the integrin a8-encoding gene ITGA8 in two families. Itga8 homozygous knockout in mice is known to result in
absence of kidney development. We provide evidence of a damaging effect of the human ITGA8 mutations. These results demonstrate
that mutations of ITGA8 are a genetic cause of bilateral renal agenesis and that, at least in some cases, bilateral renal agenesis is an auto-
somal-recessive disease.Congenital abnormalities of the kidney and urinary tract
(CAKUT) are frequently observed in children and represent
a significant cause of morbidity, accounting for more than
40% of pediatric end-stage renal failure.1 The most severe
forms lead to perinatal death or justify termination of preg-
nancy. Among CAKUT defects, renal hypodysplasia (RHD
[MIM 191830]) is a heterogeneous condition encompass-
ing a spectrum of kidney development defects including
renal agenesis, hypoplasia, and cystic and noncystic
dysplasia. Although most RHD cases are simplex, the
occurrence of familial and syndromic cases indicates the
existence of a genetic component.
Kidney development is initiated by a reciprocal induc-
tion between the ureteric bud (UB) and the metanephric
mesenchyme (MM). Reiteration of this process induces
branching of the UB to form the collecting ducts and
mesenchyme-to-epithelial differentiation of the MM to
generate the nephrons. Kidney development is orches-
trated by a large number of genes encoding transcription
factors, signaling and adhesion molecules, and extracel-
lular matrix proteins. Mutations in ~15 of these genes
have been reported in individuals with RHD, demon-
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with syndromic RHD, affect the transcription factor encod-
ing PAX2 (renal-coloboma syndrome [MIM 120330]), EYA1
and SIX2 (branchio-oto-renal syndrome [MIM 113650]),
and HNF1B (renal cysts and diabetes association [MIM
137920]).2–6 Other rarer forms of syndromic RHD are asso-
ciated with mutations in SALL1 (Townes-Brocks syndrome
[MIM 107480]), KAL1 (Kallman syndrome [MIM 308700]),
FRAS1 and FREM2 (Fraser syndrome [MIM219000]), FREM1
(bifid nose and anorectal and renal anomalies [MIM
608980]), GATA3 (RHD, hypoparathyroidism, and sensori-
neural deafness [MIM 146255]), GLI3 (Pallister-Hall syn-
drome [MIM 146510]), LRP4 (Cenani-Lenz syndrome
[MIM 212780]), or RET (Hirschsprung disease [MIM
142623] andCAKUT).7–15Mutations inmost of these genes
and a few others (e.g., BMP4) have also been described in in-
dividuals with isolated RHD.16,17 Almost all the mutations
reported to date are heterozygous, suggesting that haploin-
sufficiency is a common mechanism leading to RHD.
Genotype-phenotype correlation analyses show that the
severity of the renal defects associated with mutations in a
given gene can be extremely variable. This is notably well
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it is striking that these two genes, whose mutations can
lead to very severe phenotypes, diagnosed in utero and
justifying termination of pregnancy, have not been re-
ported to date as mutated in fetuses with bilateral renal
agenesis (BRA).18 It was proposed that heterozygous loss-
of-function mutations in RET, encoding the GDNF recep-
tor (which plays a crucial role in branching of the UB),
could be a major mechanism leading to isolated BRA.19
However, this was questioned by another study based on
a larger series of cases.20 The genetic mechanisms leading
to BRA thus remain largely unresolved.
Absence of kidney development is reported in a large
number of homozygous knockout mouse models (>45
knockout genes associated with the phenotype ‘‘absent
kidney’’ in the Mouse Genome Informatics [MGI] data-
base), suggesting that BRA in humans could be due to
recessive mutations in some of these genes. Accordingly,
by whole-exome sequencing, we have recently identified
a homozygous mutation in FGF20 in fetuses with BRA
from a consanguineous family.21 By the same approach,
we analyzed ten other families with BRA cases. In two of
these families, we identified recessivemutations in another
gene with a major role during kidney development, the
integrin a8-encoding gene ITGA8.22
Family F1 was a consanguineous Roma (Gypsy) family
originating from Serbia and Spain. In this large family,
three couples experienced one to four terminations of
pregnancy for BRA associated with the Potter sequence
due to anhydramnios (facial dysmorphism, pulmonary
hypoplasia, and clubbed feet). DNA from three fetuses
and the mother of one of them was available for analysis
(Figure 1A and Figure S1 available online). Family F2 was
a nonconsanguineous family originating from Guinea-Bis-
sau (Figure 1B). F2-1 (II-2 in Figure 1B) was a fetus, sponta-
neous aborted in the 24th gestational week for BRA with
anhydramnios. F2-2 (II-3 in Figure 1B) died perinatally
and presented with BRA and bilateral cryptorchidism.
DNA from F2-1, F2-2, and their parents was available.
The study was approved by the Comite´ de Protection des
Personnes pour la Recherche Biome´dicale Ile de France 2
and informed consent was obtained from the parents.
Whole-exome sequencing was performed for individuals
F1-1 (II-3 in Figure 1A), F2-1, and F2-2 via the 50 Mb Agi-
lent SureSelect all exon V3 and a SOLiD4 (Life Technolo-
gies) sequencer (50 base fragment reads) for F1-1 and the
51 Mb Agilent SureSelect all exon V5 and the HiSeq2500
(Illumina) sequencer (paired-end 76-76 base reads) for
F2-1 and F2-2. Sequence data were aligned to the human
genome reference sequence (UCSC Genome Browser,
hg19 build) by the Lifescope suite from Lifetech (SOLID)
or BWA aligner (Hiseq).23 Downstream processing was
carried out with the Genome Analysis Toolkit (GATK),
SAMtools, and Picard.24 Variants were annotated with a
software system developed by the Paris Descartes Uni-
versity Bioinformatics Platform, based on the Ensembl
(release 72), dbSNP (135), EVS (ESP6500SI-V2), and 1000
Genomes (May 2011) databases.The AmericMean coverage was 45, 53, and 52, with 75% of the tar-
geted bases covered at least 5 times for individual F1-1 and
99% for F2-1 and F2-2. Prioritization of the variants was
performed by the following strategy: (1) filtration of the
variants present in public databases or in our in-house
exome database; (2) selection of genetic variants located
in the coding regions or splice sites and with a predicted
deleterious effect on the protein (Polyphen2, Sift); and
(3) expression of the selected candidate genes in early kid-
ney development (GUDMAP database). For F1-1 belonging
to a consanguineous family, we looked for homozygous
variants and identified three candidate genes, whereas for
F2-1 and F2-2 we focused on compound heterozygous var-
iants common to both cases, which were detected in four
genes (Table S1). Interestingly, ITGA8was one of the candi-
date genes in both families. Because of its crucial role for
renal development, this gene was a very good candidate
whose mutations could explain the lack of kidneys in
the fetuses. Indeed, integrin a8 is expressed in the MM,
notably in the cap mesenchyme surrounding the UB,
and, in association with integrin b1, signals though bind-
ing with nephronectin, an extracellular ligand produced
by the UB, for activation of the expression of GDNF.25
Itga8 knockout mice display renal agenesis resulting from
an altered invasion of the MM by the UB.22
A homozygous 50-splice variant (c.2982þ2T>C [RefSeq
accession number NM_003638.1]) was detected in fetus
F1-1 from family F1 (Figure 1A, Table S1). The mutation
was predicted to affect splicing. Sequencing of a fetal
lung cDNA fragment spanning exons 27 to 30 allowed us
to demonstrate that the mutation led to total skipping of
exon 28, resulting in in-frame deletion of 34 amino acids
(p.Arg961_Ala994del) (Figure 1A). By Sanger sequencing,
we showed that the two other fetuses of the family
with DNA available were also homozygous for the muta-
tion, and the mother of fetus F1-3 was heterozygous
(Figure S1). Although the c.2982þ2T>C variant was absent
from public as well as our in-house databases, we sought
to determine its frequency in the Gypsy population. We
analyzed a panel of 541 unrelated anonymized Gypsy
controls from three different migratory populations,
comprising multiple endogamous groups (Vlax, 190 sam-
ples; Balkan, 238 samples; Western European, 113 samples
including 57 Spanish Roma).26 The mutation screening
was performed by high-resolution melting (LightCycler
480 Real-Time PCR System, Roche) with primers CAGC
AAAACTCCCAGAAGGA and TTGGTGAGCTGAAGAG
GAAA producing a 160 bp fragment spanning the varia-
tion. Two heterozygous individuals were identified in the
Balkanic population (confirmed by Sanger sequencing),
resulting in an overall allelic frequency of 0.04% in Balkan
Gypsy groups. This suggests that the ITGA8 c.2982þ2T>C
change is a rare variant in the Gypsy population family F1
originates from.
In family F2, we identified compound heterozygosity
in F2-1 and F2-2: a 5 base pair deletion in exon
17 (c.1622_1626delAGGTG) resulting in a frameshiftan Journal of Human Genetics 94, 288–294, February 6, 2014 289
Figure 1. Identification of Recessive
ITGA8 Mutations in Two Families with
Bilateral Renal Agenesis
(A) Characterization of a homozygous 50
splice site mutation, c.2982þ2T>C, in
consanguineous family F1. Pedigree of
branch F1(a) of the family, with three
fetuses with bilateral renal agenesis (in
black) and one child with unilateral renal
agenesis (in gray). Exome sequencing was
performed for fetus F1-1 (II-3 in the pedi-
gree), leading to the identification of
the c.2982þ2T>C homozygous mutation
(RefSeq NM_003638.1). For validation of
the effect of this mutation on splicing,
RT-PCR analysis of the ITGA8 transcript
was performed on fetal lung cDNAs of F1-
1 and a control, using primers located in
exons 27 and 30. Whereas a 347 bp band
corresponding to normal splicing was ob-
tained for the control, a 245 bp band was
amplified for fetus F1-1. Sanger sequencing
of the 245 bp fragment confirmed that the
c.2982þ2T>C mutation leads to aberrant
splicing and skipping of exon 28, resulting
in in-frame deletion of 34 amino acids
(p.Arg961_Ala994del).
(B) Characterization of compound hetero-
zygous mutations in family F2. Exome
sequencing was performed for F2-1 and
F2-2 with bilateral renal agenesis (II-2 and
II-3 in the pedigree), leading to the identi-
fication of two heterozygous mutations, a
5 bp deletion in exon 17 (c.1622_1626de-
lAGGTG) resulting in a frameshift and
a truncated protein (p.Glu541Alafs*12),
and a point mutation in exon 13
(c.1219G>A) resulting in a missense
change (p.Gly407Arg). Sanger sequencing
chromatograms showing paternal origin
of the deletion and maternal origin of the
missense are presented.
(C) Structure of the ITGA8 protein in bent (inactive) configuration, designed with the Phyre2 program and visualized with PyMOL. The
position of the part of the protein that is deleted as a consequence of the homozygous splicemutation identified in family F1 is shown in
orange (p.Arg961_Ala994del), the position of the amino acids that are changed as a consequence of the compound heterozygous mu-
tations identified in family F2 are in red (p.Gly407Arg and p.Glu541Alafs*12), and the position of the amino acid that is changed as a
result of the heterozygous mutation identified by Sanger sequencing in a simplex BRA case is in magenta (p.Thr255Met). The protein
domains are numbered from N-ter to C-ter: 1, seven-bladed b propeller head domain; 2, thigh domain; 3, calf1 domain; 4, calf2 domain
(domains 1–4 constituting the extracellular part of the protein); 5, transmembrane domain; 6, intracellular domain.(p.Glu541Alafs*12) and a point mutation (c.1219G>A) in
exon 13 leading to a missense (p.Gly407Arg) with a pre-
dicted damaging effect (Polyphen2 ¼ 1/Sift ¼ 0.01)
(Figure 1B, Table S1). The deletion was absent from variant
databases and the missense is reported once in EVS, with a
very low frequency (1/13,005). By analysis of the parents’
DNA, we demonstrated that the two mutations were
located on different alleles.
Integrins are noncovalently bound ab heterodimeric
transmembrane receptors that mediate various biological
functions, notably cell adhesion, cytoskeleton rearrange-
ment, and activation of cell signaling pathways, through
conformational changes and interaction with extracellular
ligands.27 These processes play a major role during organ-
ogenesis and epithelial organization, and lack of integrin
a8, integrin b1, or the a8b1 ligand nephronectin dramati-290 The American Journal of Human Genetics 94, 288–294, Februarycally affects kidney development in mice.22,25,28 The a
chain consists of four extracellular domains, a transmem-
brane helicoidal domain, and a small intracellular tail.27
With the Phyre2 and PyMOL softwares, we analyzed
the position of the variations relative to these domains
(Figure 1C). The splice mutation identified in family F1
leads to the deletion of two blade-shaped b sheets in calf
2 domain, which probably destabilizes the structure of
this whole domain. It is expected that this should affect
the conformation of the a8b1 heterodimer and the transi-
tion from bent and inactive to extended and active confor-
mation necessary for interaction with nephronectin.27 In
family F2, the p.Gly407Arg missense change, occurring
in combination with a frameshift mutation that results
in a truncated protein in calf 1 domain, is located in one
of the seven blade-shaped b sheets of the b propeller,6, 2014
Figure 2. Analysis of the Subcellular
Localization of the ITGA8 p.Gly407Arg
Protein
(A) Analysis of the subcellular localization
of WT and variant ITGA8 proteins by
immunofluorescence: 2 3 105 HEK293
cells transiently transfected with plasmid
constructs containing the WT or the
mutated ITGA8 cDNA cloned in pcDNA3
were plated on slides previously coated
for 1 hr at 37C with 10 mg/ml of nephro-
nectin (R&D Systems) and rinsed for an
additional 1 hr with 1% BSA/PBS. After a
24 hr incubation at 37C, cells were fixed
with PFA 4%. For cell permeabilization,
a 10 min treatment with Triton 0.2% in
PBS was applied before incubation with
the antibodies. The following primary
antibodies were used in 1% BSA/PBS:
rabbit anti-integrin a8 1/100 (Sigma-
Aldrich) and mouse anti-PDI 1/200 (Assay
designs).
(B and C) Analysis of a8 integrin at the cell
surface by flow cytometry.
(B) HEK293 cells were stably transfected
with WT or mutated ITGA8 cDNA con-
structs or empty pcDNA3 vector and
ITGA8 protein level was controlled by immunoblot (rabbit anti-integrin a8 1/1,000, mouse anti-GAPDH [Millipore] 1/3,000).
(C) For flow cytometry analysis, cells were detached from culture plates with a Costar cell lifter. Cell pellets were incubated with rabbit
anti-integrin a8 antibody (1/50) for 30 min at room temperature in 3% BSA/PBS. After washing with PBS, cells were labeled with second-
ary antibody (polyclonal donkey anti rabbit, Alexa Fluor 488, 1/1,000). Cells were fixed with 1% PFA/PBS and the amount of a8 integrin
at the surface was measured with FACS Calibur (Becton Dickinson). Data were analyzed with the CELLQuest program (Becton Dickin-
son). Negative control was cell line ITGA8 WT incubated with secondary antibody alone (black curve).suggesting that it also affects the function of the protein
(Figure 1C).
In order to validate the effect of this amino acid change,
the c.1219G>A mutation was introduced by site-directed
mutagenesis in a human WT ITGA8 cDNA cloned in
pcDNA3.1.29 The WT and mutated ITGA8 constructs
were transiently transfected in HEK293 cells, which do
not endogenously express ITGA8.30 We characterized the
subcellular localization of ITGA8 by immunofluorescence
in nonpermeabilized and permeabilized cells. Although
both ITGA8 WT and ITGA8 p.Gly407Arg proteins could
be detected in the cytoplasm of permeabilized cells where
they colocalize with a marker of the endoplasmic reticu-
lum (Figure 2A, left), only the WT protein was detected
at the cell surface in nonpermeabilized cells (Figure 2A,
right). These results suggested that the p.Gly407Arg
variant protein was unable to reach the plasma membrane
and was retained in the reticulum. In order to go further in
the functional characterization of this protein variant, we
generated stably transfected cell lines. We evaluated the
ITGA8 mRNA and protein levels in the two cell lines by
quantitative RT-PCR (not shown) and immunoblot
(Figure 2B). Absence of the ITGA8 p.Gly407Arg protein at
the cell surface was confirmed by flow cytometry analysis
(Figure 2C).
Then, we analyzed the effect of the mutation on cell
adhesion and spreading, two mechanisms that are regu-
lated by integrins. Cell adhesion (Figure 3B) and spreading
(Figure 3C) were observed by immunofluorescence afterThe Americstaining for the actin cytoskeleton and focal adhesions
(phalloidin and paxillin, respectively; Figure 3A). In paral-
lel, we used the xCELLigence technology (ACEA Bio-
sciences, Roche), which allows real-time analysis of cell
index, an arbitrary value representing the number of
adherent cells and the intensity of their interaction with
the substrate (Figure 3D). ITGA8 WT cells showed both
increased adhesion and spreading on nephronectin
compared to ITGA8 p.Gly407Arg cells and to control cells,
as visualized by the number of adherent cells and the pro-
portion of extensively spread cells (Figures 3A–3C). This
was confirmed by analysis of cell index by xCELLigence,
showing that presence of ITGA8 WT led to a two times in-
crease in cell adhesion velocity, represented by the slope of
the curves over 45 min from seeding, compared to ITGA8
p.Gly407Arg (Figures 3D and 3E). Altogether, these results
demonstrate that the p.Gly407Arg change affects localiza-
tion of ITGA8 at the plasma membrane and consequently
integrin a8b1-dependent cell adhesion and spreading.
Finally, in order to identify other ITGA8 mutations,
we performed Sanger sequencing of the 30 exons of the
gene in a cohort of 57 fetuses with bilateral RHD (47
with BRA, 10 with unilateral renal agenesis and hypodys-
plasia). Seven cases were familial cases. No other recessive
mutation was identified. However, one fetus with BRA
carried a heterozygous missense variant (c.764C>T
[p.Thr255Met]). This variant is not a reported polymor-
phism and is predicted to be damaging (Polyphen2 ¼
0.999/Sift ¼ 0). As for the p.Gly407Arg missense change,an Journal of Human Genetics 94, 288–294, February 6, 2014 291
Figure 3. Characterization of the Effect of the ITGA8 p.Gly407Arg Variation on Cell Adhesion and Spreading
(A–C) Analysis of adhesion and spreading by immunofluorescence.
(A) For each cell line, 2 3 105 cells were plated on glass slides previously coated with nephronectin. After a 45 min incubation at 37C,
cells were fixed with PFA 4%. Staining of ITGA8 (rabbit anti-integrin a8 1/100), filamentous actin (rhodamine coupled phalloidin 1/400,
Sigma-Aldrich), and paxillin (mouse anti-paxillin 1/50, BD Biosciences) showed enhanced spreading of ITGA8 WT cells compared to
ITGA8 p.Gly407Arg cells.
(B) Cell adhesion was measured by counting the number of adhered cells in 12 fields (at magnification 363) for each cell line.
(C) The percentage of spread and unspread cells was estimated by counting of 100 cells for each cell line (light gray, unspread; medium
gray, weakly spread; black, strongly spread).
(D and E) Lifetime cell adhesion and spreading was evaluated with the impedance-based system xCELLigence (ACEA Biosciences,
Roche). E-type plates were coated for 1 hr at 37C with 10 mg/ml of nephronectin (Npnt) and rinsed for an additional 1 hr with 1%
BSA/PBS. 8 3 104 stably transfected HEK293 cells (ITGA8 WT, ITGA8 p.Gly407Arg, or empty pcDNA3) were seeded in each well.
(D) Cell index (CI) wasmeasured from 25min after seeding. Each CI value corresponds to the average of triplicates5 standard deviation
(red curves, ITGA8 WT; blue curves, ITGA8 p.Gly407Arg; black curves, empty pcDNA3).
(E) Adhesion velocity is represented as the slope of the curves, calculated on the first 45min after seeding (indicated by the vertical line in
D). The graph represents the mean5 SEM of two independent experiments, each one in triplicate. **p < 0.01 calculated by t test.the p.Thr255Met change is located in one of the blade-
shaped b sheets of the b propeller domain, suggesting
that is could also affect the function of the protein
(Figure 1C). Although the second mutation remains to be
identified, alteration of ITGA8 could also be the causative
mechanism of BRA in this fetus.
In conclusion, our results demonstrate that recessive
ITGA8mutations can cause BRA in humans. Accurate eval-292 The American Journal of Human Genetics 94, 288–294, Februaryuation of the frequency of ITGA8 mutations associated
with this phenotype, as well as of the potential variability
of the kidney development defects resulting from these
mutations, will require analysis of a larger series of families.
However, our identification of ITGA8 mutations in two
families out of ten analyzed by whole-exome sequencing
suggests that ITGA8 mutations could be a frequent cause
of familial BRA. These results also clearly confirm the6, 2014
hypothesis that the most severe forms of human RHD,
notably BRA, can be autosomal-recessive disorders, as
observed in mouse models with severe kidney develop-
ment defects.Supplemental Data
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